“Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy”, GJSFR, vol. 24, no. G1, pp. 1–3, Nov. 2024, doi: 10.34257/GJSFRGVOL24IS1PG1.